Skip to main content
. 2022 Mar 30;221(5):e202107016. doi: 10.1083/jcb.202107016

Table 1.

Alanine substitutions and phosphorylation levels measured for the engineered Dam1 complexes used in this study.

Complex Ndc80 interaction regions Other phospho-sites Incorporation of [γ-32P]ATP
Interactions A B C (NA) Moles phosphoryl group per mole Dam1p Moles phosphoryl group per mole Ask1p Moles phosphoryl group per mole Spc34p
Dam1c subunit Dam1p Ask1p Spc34p Dam1p
Residues S257 S265 S292 S200 T199 S20 S31 S311
Wild-type S S S S T S S S 2.6 ± 0.41 ND 1.2 ± 0.04
S20A S S S S T A S S 2.1 ± 0.10 ND 1.0 ± 0.20
ADam1p S S S A A A S S 2.3 ± 0.51 None None
BAsk1p A A A S A A S S 0.90 ± 0.05 0.7 ± 0.09 None
CSpc34p A A A A T A S S 0.77 ± 0.14 None 0.93 ± 0.15
ADam1pBAsk1p S S S S A A S S 2.6 ± 0.87 ND None
ADam1pCSpc34p S S S A T A S S 1.9 ± 0.56 None 0.75 ± 0.03
BAsk1pCSpc34p A A A S T A S S 0.80 ± 0.11 0.61 ± 0.10 0.92 ± 0.14
6A A A A A A A S S 0.72 None None

Alanine substitutions blocked phosphorylation at indicated sites (bold A's), so treatment with Ipl1 kinase and ATP led to phosphorylation specifically at sites that remained unmodified (S or T). Phosphorylation levels on Dam1p, Spc34p, and when possible, Ask1p were quantified as described in Materials and methods. NA, not applicable; ND, not determined.